Curis (CRIS) Stock Price, Quote, News & History | Benzinga

SPY774.94+0.01%QQQ756.43+0.03%BTC/USD85,199.99−0.64%DIA512.59+0.09%GLD379.00−0.14%TLT77.13+0.03%

Curis Inc (CRIS) Stock Price, Quote, News & History

CRISNASDAQ

Trade with Public

Trade with Public

$0.7890

-0.0144-1.79%

Last update: Oct 5, 7:04 PM

$0.7990

-0.0044-0.55%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$0.81

Close

$0.79

Volume / Avg.

557.50K / 186.25K

Day Range

$0.72 - $0.82

52 Wk Range

0.80 - 34.80

Market Cap

$1.94M

P/E Ratio

0.22

Dividend Yield

-

Exchange

NASDAQ

RSI

17

Short Interest

2.87%

Days to Cover

1

Recent Curis Inc News

Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus

Curis gained attention after positive emavusertib data as analyst raised its price target to $43 and highlighted upcoming trial catalysts.

Vandana Singh

Curis Strengthens Oncology Pipeline Outlook With Strong TakeAim Lymphoma Response Rates

Curis shares positive updated clinical data for emavusertib and increases its year-end guidance for the TakeAim CLL study.

Vandana Singh

Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Gainers: Q32 Bio up 29.6%, Mint up 75.8%, Fast Track up 58.2%, eLong up 33.4%, Sobr Safe up 29.2%, Eshallgo up 20.3%, Curis up 10.9%, Sky Quarry up 10.6%, Accuray up 9.5%, Bitzero up 5.5%. Losers: Global Mofy down 25.3%, Jiuzi down 22.1%, Julong down 21.4%, Haoxi down 20.4%, Sadot down 20.4%.

Avi Kapoor

Why Did Curis (CRIS) Stock Soar After Hours?

Curis, Inc. shares surged 8.51% after the bell after the company confirmed its approved reverse stock split will take effect on Thursday.

Mohd Haider

Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announcing acquisition of Best Praise International for $10.75 million.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-30.59M

Investing Cash Flow (TTM)

2.50M

Financing Cash Flow (TTM)

23.02M

Free Cash Flow (TTM)

-30.59M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-5.07M

Analyst Trends and Forecast

1

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$2.14M

PE Ratio (TTM)

0.22

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.22

PB Ratio (TTM)

0.42

Earnings Yield % (TTM)

453.42%

Earnings Yield % (FWD)

-393.79%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.94

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$5.07M

Debt to Equity

0.22

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-